OCM
One Capital Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $442K | Sell |
52,396
-328,047
| -86% | -$2.77M | 0.02% | 374 |
|
2025
Q1 | $3.02M | Sell |
380,443
-339,371
| -47% | -$2.7M | 0.1% | 144 |
|
2024
Q4 | $6.99M | Sell |
719,814
-10,129
| -1% | -$98.4K | 0.23% | 98 |
|
2024
Q3 | $8.21M | Buy |
729,943
+49,632
| +7% | +$558K | 0.26% | 97 |
|
2024
Q2 | $7.1M | Buy |
680,311
+123,339
| +22% | +$1.29M | 0.24% | 94 |
|
2024
Q1 | $6.34M | Buy |
556,972
+50,624
| +10% | +$576K | 0.23% | 97 |
|
2023
Q4 | $5.85M | Sell |
506,348
-33,930
| -6% | -$392K | 0.23% | 100 |
|
2023
Q3 | $5.49M | Buy |
540,278
+23,889
| +5% | +$243K | 0.24% | 97 |
|
2023
Q2 | $6.26M | Buy |
516,389
+53,178
| +11% | +$645K | 0.28% | 88 |
|
2023
Q1 | $5.71M | Buy |
463,211
+17,337
| +4% | +$214K | 0.28% | 97 |
|
2022
Q4 | $5.64M | Buy |
445,874
+30,773
| +7% | +$389K | 0.3% | 93 |
|
2022
Q3 | $5.21M | Buy |
415,101
+2,422
| +0.6% | +$30.4K | 0.31% | 86 |
|
2022
Q2 | $5.04M | Buy |
412,679
+55,788
| +16% | +$682K | 0.3% | 86 |
|
2022
Q1 | $5.36M | Buy |
+356,891
| New | +$5.36M | 0.28% | 93 |
|